Search
Members area
News
Bio-Path Holdings Announces Dosing of First Patient in a Phase I Clinical Trial of Its Liposomal Grb-2 Cancer Drug Candidate
Donnerstag, 05 August 2010
BUSINESS WIRE, July 29, 2010
A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Donnerstag, 05 August 2010
Ahn R.W., Chen F., Chen H., Stern S.T., Clogston J.D., Patri A.K., Raja M.R., Swindell E.P., Parimi V., Cryns V.L.,
O'Halloran T.V.
Clin Cancer Res; 16(14); 3607–17. ©2010 AACR.
Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery
Mittwoch, 04 August 2010
Sawanta R.R., Vazea O.S., Rockwella K., Torchilin V.P.
European Journal of Pharmaceutics and Biopharmaceutics, Volume 75, Issue 3, August 2010, Pages 321-326
SRMS142-based solid lipid microparticles: Application in oral delivery of glibenclamide to diabetic rats
Mittwoch, 04 August 2010
Nnamani P.O., Attama A.A., Ibezim E.C., Adikwu M.U.
European Journal of Pharmaceutics and Biopharmaceutics, In Press, Corrected Proof, Available online 8 June 2010
Distearoyl-phosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery
Mittwoch, 04 August 2010
Evjen T.J., Nilssena E.A., Rögnvaldssona S., Brandl M., Fossheima S.L.
European Journal of Pharmaceutics and Biopharmaceutics, Volume 75, Issue 3, August 2010, Pages 327-333
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Mittwoch, 04 August 2010
Phospholipid Research Center: Fricker G., Kromp T., Wendel A., Blume A., Zirkel J., Rebmann H., Setzer C., Quinkert R.-O., Martin F., Müller-Goymann C.
Pharm Res., 2010, Vol 27, No. 8 August: 1468-1486, DOI: 10.1007/S11095-010-0130-X
Newsflash
Distearoyl-phosphatidylethanolamine-based liposomes for ultrasound-mediated drug delivery
Evjen T.J., Nilssena E.A., Rögnvaldssona S., Brandl M., Fossheima S.L.
European Journal of Pharmaceutics and Biopharmaceutics, Volume 75, Issue 3, August 2010, Pages 327-333
Activities
The latest issues of our newsletter here...